Covered recipient · General Payments record
BRUCE E SILVERSTEIN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$5,625.83
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $773.37 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $300.74 | 9 |
| Tarsus Pharmaceuticals, Inc. | $159.43 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $145.38 | 1 |
| Alcon Laboratories Inc | $103.56 | 2 |
| GLAUKOS CORPORATION | $25.93 | 1 |
| BIOTISSUE HOLDINGS INC. | $23.38 | 1 |
| Amgen Inc. | $14.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.29 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106104033 | CMS |
| ABBVIE INC. | $104.20 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106104035 | CMS |
| ABBVIE INC. | $24.78 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106104037 | CMS |
| ABBVIE INC. | $27.72 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106104039 | CMS |
| ABBVIE INC. | $18.95 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106104041 | CMS |
| ABBVIE INC. | $21.86 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106104043 | CMS |
| ABBVIE INC. | $19.57 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106104045 | CMS |
| ABBVIE INC. | $18.22 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106104047 | CMS |
| ABBVIE INC. | $31.15 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106104049 | CMS |
| Alcon Vision LLC | $16.98 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110571715 | CMS |
| Alcon Vision LLC | $86.58 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110571717 | CMS |
| Amgen Inc. | $14.95 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117684644 | CMS |
| BIOTISSUE HOLDINGS INC. | $23.38 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148748618 | CMS |
| Glaukos Corporation | $25.93 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151985504 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $145.38 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152132170 | CMS |
| Tarsus Pharmaceuticals, Inc. | $159.43 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139132628 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.